|The Role of Maintenance/Consolidation Therapy in Multiple Myeloma: A Patient-Centered Approach|
Jacob Laubach, MD
|Release Date: November 08, 2017|
Expiration Date: November 08, 2018
Maintaining results of successful induction therapy is an important goal in the treatment of multiple myeloma. Recent advances in maintenance therapy indicate it is a viable approach, resulting in longer progression-free survival and, more importantly, overall survival. Ideally, maintenance therapy should sustain treatment responses, have good safety and tolerability profiles in long-term use, and be convenient for patients. Join Dr. Laubach as he navigates through a series of case presentations to provide you with the latest evidence and advances in clinical research to consider in this patient population.Provided by MediCom Worldwide, Inc.
This activity is supported by educational grants from Celgene Corporation and Takeda Oncology
|Begin, Earn CreditView Only, No Credit|